WSAU News |
Sanofi beefing up diabetes pipeline, sees growth returning
Reuters The company had previously forecast diabetes revenue to shrink by 4 to 8 percent a year on average over 2015-2018 as its patent-expired Lantus insulin is being squeezed by pricing pressure in the United States, the world's-largest health market ... Sanofi beefs up diabetes pipeline to retrieve success |
from diabetes - Google News
![[OC] Build Your Own Dexcom App update- base version updates](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
Social Plugin